Zhejiang Deyer Pharmaceutical

Zhejiang Deyer Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. The company primarily focuses on cardiovascular treatments, particularly the "sartan" family of angiotensin II receptor blockers such as Valsartan and Irbesartan. Operating out of Huzhou, Zhejiang, the firm provides high-quality chemical synthesis services and products to both domestic and international markets. Their facilities are designed to meet global Good Manufacturing Practice (GMP) standards, supporting their role as a key supplier in the pharmaceutical supply chain. The company is dedicated to process optimization and the production of high-purity chemical compounds for the life sciences industry.